//--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~isPartOf:"Harvard business review : HBR"
~isPartOf:"Journal of health economics"
~isPartOf:"Journal of research in pharmaceutical economics"
~subject:"Markteintritt"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject_exact:"Arzneimittelindustrie"
Narrow search
Delete all filters
| 4 applied filters
Year of publication
From:
To:
Subject
All
Markteintritt
Pharmaceutical industry
67
Pharmaindustrie
67
Pharmaceuticals
34
Arzneimittel
33
USA
21
United States
21
Arzneimittelmarkt
15
Pharmaceutical market
15
Innovation
10
Gesundheitskosten
9
Health care costs
9
Industrial research
9
Industrieforschung
9
Regulation
9
Regulierung
9
Pharmacology
7
Pharmakologie
7
Preisregulierung
7
Price regulation
7
Theorie
7
Theory
7
Health insurance
6
Krankenversicherung
6
Competition
5
Gesundheitspolitik
5
Health policy
5
Market entry
5
Wettbewerb
5
Generic drugs
4
Generika
4
Gesetzliche Krankenversicherung
4
Kanada
4
Patent
4
Preismanagement
4
Pricing strategy
4
Public health insurance
4
Advertising
3
Arzneimittelrecht
3
Biotechnologie
3
more ...
less ...
Online availability
All
Undetermined
2
Type of publication
All
Article
5
Type of publication (narrower categories)
All
Article in journal
5
Aufsatz in Zeitschrift
5
Language
All
English
5
Author
All
Castanheira, Micael
1
Gorecki, Paul K.
1
Grossmann, Volker
1
Ornaghi, Carmine
1
Panattoni, Laura E.
1
Sanzenbacher, Geoffrey
1
Siotis, Georges
1
Wettstein, Gal
1
more ...
less ...
Published in...
All
Harvard business review : HBR
Journal of health economics
Journal of research in pharmaceutical economics
NBER working paper series
8
Handbuch Market-Access : Marktzulassung ohne Nebenwirkungen
7
NBER Working Paper
6
Review of industrial organization : RIO
5
Working paper / National Bureau of Economic Research, Inc.
5
Discussion papers / Deutsches Institut fĂĽr Wirtschaftsforschung
4
International journal of industrial organization
4
International journal of pharmaceutical and healthcare marketing : IJPHM
3
Strategic management journal
3
The review of economics and statistics
3
Intereconomics : review of European economic policy
2
International journal of the economics of business
2
Management science : journal of the Institute for Operations Research and the Management Sciences
2
Marketing science : the marketing journal of the Institute for Operations Research and the Management Sciences
2
Münchener Wirtschaftswissenschaftliche Beiträge : VWL ; discussion papers
2
The European journal of health economics : HEPAC ; health economics in prevention and care
2
The Rand journal of economics
2
UmeĂĄ economic studies
2
Working paper
2
Working papers / Bureau of Economics, Federal Trade Commission
2
Advances in management & applied economics
1
American economic journal
1
Applied economics
1
Atlantic economic journal : AEJ
1
Augsburger Schriften zum Arzneimittel- und Medizinprodukterecht
1
Bank of Finland research discussion papers
1
Barcelona GSE working paper series : working paper
1
Brazilian review of econometrics : BRE ; the review of the Brazilian Econometric Society
1
Brookings papers on economic activity / Microeconomics
1
DEM working paper series
1
DIW Berlin Discussion Paper
1
Department of Economics working paper
1
Die politische Konstitution von Märkten
1
Discussion papers / CEPR
1
Discussion papers / Governance and the Efficiency of Economic Systems
1
Dynamic optics in economics : quantitative, experimental and econometric analyses
1
ECARES working paper
1
ERID working paper
1
Economic Research Initiatives at Duke (ERID) Working Paper Series
1
more ...
less ...
Source
All
ECONIS (ZBW)
5
Showing
1
-
5
of
5
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Drug insurance and the strategic behavior of drug manufacturers : evergreening and generic entry after Medicare Part D
Sanzenbacher, Geoffrey
;
Wettstein, Gal
- In:
Journal of health economics
72
(
2020
),
pp. 1-13
Persistent link: https://www.econbiz.de/10012495216
Saved in:
2
The unexpected consequences of generic entry
Castanheira, Micael
;
Ornaghi, Carmine
;
Siotis, Georges
- In:
Journal of health economics
68
(
2019
),
pp. 1-22
Persistent link: https://www.econbiz.de/10012419543
Saved in:
3
Do cost-sharing and entry deregulation curb pharmaceutical innovation?
Grossmann, Volker
- In:
Journal of health economics
32
(
2013
)
5
,
pp. 881-894
Persistent link: https://www.econbiz.de/10010210741
Saved in:
4
The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms
Panattoni, Laura E.
- In:
Journal of health economics
30
(
2011
)
1
,
pp. 126-145
Persistent link: https://www.econbiz.de/10009247369
Saved in:
5
Barriers to entry in the Canadian pharmaceutical industry : comments, clarification and extensions
Gorecki, Paul K.
- In:
Journal of health economics
6
(
1987
)
1
,
pp. 59-72
Persistent link: https://www.econbiz.de/10001043175
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->